Anton Dobrin

3.1k total citations · 2 hit papers
12 papers, 1.0k citations indexed

About

Anton Dobrin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Anton Dobrin has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Anton Dobrin's work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (4 papers). Anton Dobrin is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (4 papers). Anton Dobrin collaborates with scholars based in United States, China and Slovakia. Anton Dobrin's co-authors include Michel Sadelain, Zeguo Zhao, Mohamad Hamieh, Annalisa Cabriolu, Justin Eyquem, Judith Feucht, Jie Sun, Yu-Jui Ho, Josef Leibold and Jorge Mansilla‐Soto and has published in prestigious journals such as Nature, Cell and Nature Medicine.

In The Last Decade

Anton Dobrin

11 papers receiving 1.0k citations

Hit Papers

CAR T cell trogocytosis and cooperative killing regulate ... 2018 2026 2020 2023 2019 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Dobrin United States 8 885 393 360 346 234 12 1.0k
Chuang Sun United States 15 870 1.0× 390 1.0× 389 1.1× 329 1.0× 232 1.0× 18 1.1k
ChingLam W. Wong United States 7 944 1.1× 381 1.0× 359 1.0× 312 0.9× 323 1.4× 8 1.0k
Stefanie Lesch Germany 8 686 0.8× 278 0.7× 284 0.8× 211 0.6× 188 0.8× 10 798
Aruna Mahendravada United States 7 1.2k 1.4× 544 1.4× 368 1.0× 442 1.3× 419 1.8× 15 1.3k
Elizabeth L. Siegler United States 14 910 1.0× 398 1.0× 346 1.0× 444 1.3× 198 0.8× 37 1.2k
Ryan Urak United States 15 910 1.0× 402 1.0× 425 1.2× 301 0.9× 254 1.1× 31 1.1k
Simon Thomas United Kingdom 10 677 0.8× 201 0.5× 279 0.8× 266 0.8× 215 0.9× 28 773
Scott E. James United States 9 1.0k 1.2× 482 1.2× 374 1.0× 304 0.9× 392 1.7× 12 1.2k
Yan Nikhamin United States 5 705 0.8× 307 0.8× 246 0.7× 249 0.7× 248 1.1× 6 807
Aurore Morello United States 5 1.2k 1.4× 530 1.3× 340 0.9× 386 1.1× 310 1.3× 16 1.4k

Countries citing papers authored by Anton Dobrin

Since Specialization
Citations

This map shows the geographic impact of Anton Dobrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Dobrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Dobrin more than expected).

Fields of papers citing papers by Anton Dobrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Dobrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Dobrin. The network helps show where Anton Dobrin may publish in the future.

Co-authorship network of co-authors of Anton Dobrin

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Dobrin. A scholar is included among the top collaborators of Anton Dobrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Dobrin. Anton Dobrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lopez, Michael, Ivan S. Kotchetkov, Leena Halim, et al.. (2025). pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication. Cell. 189(2). 401–417.e21.
2.
Perica, Karlo, Ivan S. Kotchetkov, Jorge Mansilla‐Soto, et al.. (2025). HIV immune evasin Nef enhances allogeneic CAR T cell potency. Nature. 640(8059). 793–801. 8 indexed citations
3.
Dobrin, Anton, Yuzhe Shi, Karlo Perica, et al.. (2024). Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies. Nature Cancer. 5(5). 760–773. 11 indexed citations
4.
Zhao, Zeguo, Richard P. Koche, Chenling Xu, et al.. (2023). Disruption of SUV39H1 -Mediated H3K9 Methylation Sustains CAR T-cell Function. Cancer Discovery. 14(1). 142–157. 53 indexed citations
5.
Zhao, Zeguo, Judith Feucht, Richard P. Koche, et al.. (2023). TET2 guards against unchecked BATF3-induced CAR T cell expansion. Nature. 615(7951). 315–322. 90 indexed citations
6.
Koche, Richard P., Yosi Gozlan, David Brocks, et al.. (2022). Abstract 5583: SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells. Cancer Research. 82(12_Supplement). 5583–5583. 1 indexed citations
7.
Hamieh, Mohamad, Anton Dobrin, Annalisa Cabriolu, et al.. (2019). CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature. 568(7750). 112–116. 451 indexed citations breakdown →
8.
Feucht, Judith, Jie Sun, Justin Eyquem, et al.. (2018). Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nature Medicine. 25(1). 82–88. 373 indexed citations breakdown →
9.
Feucht, Judith, Jie Sun, Justin Eyquem, et al.. (2018). Calibrated CAR Activation Potential Directs Alternative T Cell Fates and Therapeutic Potency. Blood. 132(Supplement 1). 1412–1412. 1 indexed citations
10.
Green, Jesse A., Nicholas Arpaia, Michail Schizas, Anton Dobrin, & Alexander Y. Rudensky. (2017). A nonimmune function of T cells in promoting lung tumor progression. The Journal of Experimental Medicine. 214(12). 3565–3575. 35 indexed citations
11.
Dobrin, Anton, Pratik Saxena, & Martin Fussenegger. (2015). Synthetic biology: applying biological circuits beyond novel therapies. Integrative Biology. 8(4). 409–430. 17 indexed citations
12.
Gafencu, Anca Violeta, Marius R. Robciuc, Anton Dobrin, et al.. (2006). Tu-P7:195 Concerted action of AP1 and NFKB in APOE gene regulation by LPS in macrophages. Atherosclerosis Supplements. 7(3). 228–228. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026